Overview At Tekton Research’s Moore, OK site, Principal Investigator Dr. Lacy Anderson and team delivered outstanding performance on a complex GLP-1 medication research study, meeting their enrollment goal of 13 participants a full three months early. Despite the operational demands and numerous moving parts typical of obesity trials, the site executed with exceptional coordination, speed, … Read more
Overview At Tekton Research’s Yukon, OK site, Principal Investigator Dr. Robert Lockwood delivered standout performance in a Phase 2 migraine treatment study: meeting enrollment goals early, maintaining 100% patient retention, and achieving one of the sponsor’s highest eDiary compliance rates across all participating sites. His team’s performance not only exceeded expectations but also earned the … Read more
Objective Tekton’s Wichita, KS site with lead PI Dr. Brandon Alleman was selected to support a recent clinical trial evaluating a continuous glucose monitoring (CGM) device in pregnant women with diabetes. Pregnancy introduces unique challenges in managing glucose levels, making CGM a vital tool for optimizing maternal and fetal health. Challenge The study presented unique … Read more
Overview Tekton Research played a pivotal role in advancing a recent Alzheimer’s Disease clinical trial, demonstrating exceptional performance across enrollment, site readiness, and strategic consultation. Our team not only enrolled the study’s first patient but also exceeded initial recruitment expectations, delivering high-quality data while supporting a newly engaged Principal Investigator (PI) through our robust training … Read more
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The study required a population of generally healthy adults and demanded rapid site activation and participant enrollment to meet aggressive study timelines. Challenge Norovirus, a highly contagious virus causing gastrointestinal illness, presents significant global public health challenges. … Read more